Increased Serum Angiotensin II Is a Risk Factor of Nonalcoholic Fatty Liver Disease: A Prospective Pilot Study

Table 3

Clinical and laboratory characteristics of the study patients divided into two groups according to the FibroScan Cap value.

Variables	FibroScan Cap ()	FibroScan Cap ()	value
Age (years)			0.872
Gender (male, %)	33, 78.57%	28, 87.50%	0.371
Body weight (kg)			<0.001
BMI value			0.003
ALT (U/L)			0.074
AST (U/L)			0.374
Albumin (g/L)			0.036
CRP (mg/L)			0.198
TG (mmol/L)			0.314
CHOL (mmol/L)			0.230
HDL (mmol/L)			0.094
LDL (mmol/L)			0.107
VLDL (mmol/L)			0.377
FBG (mmol/L)			0.165
Serum insulin (mIU/L)			0.007
HOMA-IR			0.016
Ang II (pg/mL)			0.040
PRA (pg/mL)			0.427
ALD (pg/mL)			0.312
PRA/ALD			0.577
IL-18 (pg/mL)			0.343
IL-1β (pg/mL)			0.339